Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Apr 4, 2022

Dr. Jens Bjørheim is the Chief Medical Officer at Ultimovacs which is taking advantage of the environment for R&D in the science around cancer vaccines in the Oslo region of Norway. Ultimovacs is working with peptide vaccines and long peptides. These peptides will drive for a specific subgroup of immune cells called...


Apr 4, 2022

Dr. Jens Bjørheim is the Chief Medical Officer at Ultimovacs which is taking advantage of the environment for R&D in the science around cancer vaccines in the Oslo region of Norway. Ultimovacs is working with peptide vaccines and long peptides. These peptides will drive for a specific subgroup of immune cells called...


Dec 2, 2021

Bob Connelly is the CEO of Elicio Therapeutics which has figured out how to deliver immunotherapies from vaccines into the lymph nodes where they are activated to defeat cancer and infectious diseases.

Bob says, "Our overall mission is to treat many different types of cancers primarily, but even to bring our technology...


Dec 2, 2021

Bob Connelly is the CEO of Elicio Therapeutics which has figured out how to deliver immunotherapies from vaccines into the lymph nodes where they are activated to defeat cancer and infectious diseases.

Bob says, "Our overall mission is to treat many different types of cancers primarily, but even to bring our technology...


Feb 9, 2021

Joseph Hernandez, Founder and CEO, Blue Water Vaccines identifies the underlying discover about the nature of the influenza virus which is driving the development of a novel universal flu vaccine that would be administered once for lifelong immunization. The economic and health implications of this vaccine include...